News
2h
Zacks.com on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
17h
India Today on MSNUS employers to cut health benefits amid soaring weight-loss drug costs: SurveyOver half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Key Points President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.Lilly's margins could be negatively affected if the company absorbs the higher costs.However, any ...
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...
As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...
In a report released yesterday, Lance Wilkes from Bernstein maintained a Hold rating on CVS Health, with a price target of $72.00. The company’s shares closed yesterday at $63.80. Wilkes covers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results